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1. Introduction 
The first ulcerative colitis (UC)-associated carcinoma (colitic cancer) appears to have been 14-
year history of UC (Fujii et al., 2002, as cited in Crohn & Rosenberg, 1925). It is widely accepted 
that inflammation plays important roles in the development of various cancers, and indeed, 
patients with UC show an increased incidence of colorectal neoplasia, and UC-associate 
dysplasia/neoplasia represents a major cause of increased mortality in such patients. In order 
to improve the prognosis of patients with UC-associated dysplasia/neoplasia, diagnosis at an 
early or precancerous stage is crucial. Predisposition to colorectal dysplasia/neoplasia in UC is 
generally considered to depend on 2 risk factors, namely the presence of long-standing disease 
and extensive colitis (Fujii et al., 2008, as cited in Ekbom, et al., 1990, and Eaden et al., 2001). 
Thus, colitic cancers are believed to arise through a chronic inflammation-dysplasia-carcinoma 
sequence, and therefore early detection of precancerous dysplasia is very important for 
optimizing the prognosis of patients with long-standing UC. In a clinical setting, UC patients 
are monitored for dysplasia endoscopically on a regular basis, but it is difficult to discriminate 
UC-associated dysplasia/neoplasia from inflamed regenerating epithelium even by 
pathological examination. Therefore, surveillance colonoscopy with multiple random biopsies 
has been widely recommended for patients with long-standing and extensive UC. However, 
because UC-associated dysplasia/neoplasia is often difficult to detect endoscopically and to 
discriminate from inflammatory regenerative epithelium histologically, it remains a matter of 
contention whether conventional surveillance colonoscopy is effective for the early detection 
of UC-associated dysplasia/neoplasia. Here we describe the ulcerative colitis/dysplasia based 
on pathology and discuss relevant issues in arriving at the correct differential diagnosis based 
on morphological, immunohistochemical and molecular findings.  
2. Risk factor and clinicopathological characteristics of dysplasia/neoplasia 
development in the patients with ulcerative colitis 
The reported prevalence rates of colitic cancer range from 1 to 10% of all patients with UC. 
This increased risk, above that of the general population, appears approximately 8–10 years 
after the onset of the disease. The risk increases with the duration of disease and is greater in 
persons with extensive colitis (Fujii et al., 2002, as cited in Dobbins, 1984). A cumulative 
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incidence of colorectal cancer was 5–10% with UC of 20 years duration and 12–20% with UC 
of 30 years duration (Fujii et al., 2002, as cited in Levin, 1995). The risk of colorectal cancer in 
patients with left-sided colitis was considered to increase 20 years after the onset of UC. 
Moreover incidence of colitic cancer in patients with left-sided disease did not differ from 
that in patients with pancolitis. In order to detect UC-associated dysplasia/neoplasia and 
the early stages of cancer, surveillance colonoscopy has been recommended for patients 
with long-standing and extensive UC. In Japan, possibly because the number of UC patients 
with dysplasia/neoplasia is smaller than that in Western countries. We reviewed Japanese 
case reports of UC-associated dysplasia/neoplasia published between 1990 and 2002 (Fujii 
et al., 2003b). Of 118 patients with UC-associated neoplasia, 41 underwent surveillance 
colonoscopy (surveillance group), 64 did not (nonsurveillance group), and the remaining 13 
cases were unknown as to surveillance status. The 64 UC associated neoplasias including 
colitic cancer (UC associated carcinoma) in the nonsurveillance group were found by 
colonoscopy that was undertaken because of developing symptomatic episode, or for the 
evaluation of inflammation activities. The depth of tumor invasion, incidence of lymph node 
metastasis, incidence of liver metastasis, and stage in the two groups are shown in Table 1.  
 
 Surveillance (41) Nonsurveillance (64) 
Depth of neoplastic invasion   
Tis 11 11 
T1 12 5 
T2 5 6 
T3 10 30 
T4 0 6 
Unknown 3 6 
Lymph node metastasis   
Positive 4 25 
Negative 25 23 
Unknown 12 16 
Liver metastasis, positive 1 4 
Peritoneal dissemination, positive 0 7 
Dukes’ stage   
A 22 15 
B 2 8 
C 4 25 
Unknown 13 16 
Table 1. Clinicopathological features of neoplasias in the surveillance and nonsurveillance 
groups (adapted from Fujii et al., 2003b) 
Regarding depth of tumor invasion, early colorectal cancer, defined as tumor invading the 
lamina propria and/or muscularis mucosae and/or submucosa, was more frequent in the 
surveillance group than in the nonsurveillance group (60.5% vs. 27.6%). The incidence of 
lymph node metastasis was lower in the surveillance group than in the nonsurveillance group 
(13.8% vs. 52.1%). Four out of the five tumors associated with liver metastasis and, all seven 
tumors associated with peritoneal dissemination were in the nonsurveillance group. The 
distribution of Dukes’ stages in the two groups was: A/B/C, 78.6%/7.1%/14.3% in the 
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surveillance group, compared with 31.2%/16.7%/52.1% in the nonsurveillance group. Similar 
to Western countries, surveillance colonoscopy in Japan contributes to the early detection of 
UC-associated dysplasia/neoplasia. The surveillance colonoscopy appears to contribute to the 
early detection and excellent prognosis of UC-associated dysplasia/neoplasia. But it still 
remains questionable whether surveillance colonoscopy with multiple-step biopsy effectively 
enables the early detection of UC-associated dysplasia/neoplasia. 
3. The morphological, immunohistochemical and molecular finding of 
ulcerative colitis/dysplasia 
Morphological futures of macroscopic and endoscopic images, UC-associated 
dysplasia/neoplasias in the precancerous and early stages show various changes. Such 
dysplasia/neoplasias are often flat, plaque-like, and superficially elevated or even 
depressed, and frequently appear as faintly red, mildly discoloured, finely villous, and 
granular (Fig.1).  
 
 
Fig. 1. Morphological classification of dysplastic epithelium in ulcerative colitis. (adapted 
from Fujii et al., 2002)  
Macroscopic and endoscopic changes are not clear, and are sometimes missed in chronically 
inflamed epithelium. Detecting UC-associated dysplasia/neoplasias in the precancerous and 
early stages is difficult by macroscopy (Fig.2), endoscopy (Fig.3a), and stereomicroscopic 
finding (Fig.3b). We retrospectively verified the percentage of UC-associated 
dysplasia/neoplasias that was detectable endoscopically before surgical resection 
ȐYamagishi et al., 2009ȑ. When classified UC-associated dysplastic/neoplastic lesions 
according to macroscopic appearance, 79.1% lesions were of flat-type. In detail, 92.5% 
dysplasias, 80.9% Tis carcinomas, 60% T1 carcinomas were of flat (flat and superficial 
elevated type), whereas 6 of 7 (85.7%) T2-4 carcinomas were protruding (polypoid type). In 
each T category, the detection rare of lesions tends to be high in the protruding appearance 
(Table 2). Most of the undetectable lesions were the flat or flat-elevated type 
macroscopically. Thus, endoscopic detection of UC-associated dysplasia/neoplasias at the 
precancerous and early stage appears to be difficult. Therefore, improvements to the current 
methods of colonoscopy are needed in order to detect UC-associated dysplasia/neoplasias 
more effectively and accurately. On the other hand, several Japanese investigators reported 
that observation of the configuration of the outlet of the colorectal surface lesion using high-
resolution endoscopy, chromoendoscopy (Fujii et al., 2008, as cited in Rembacken, et al., 
2000, and Kudo et al., 1994), increasingly useful for diagnosing and treating colorectal 
neoplasia. Recent reported the usefulness of high-resolution endoscopy, chromoendoscopy, 
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and new endoscopic system (NBI, FICE, i-scan) for detecting UC associated dysplasia 
・neoplasia (East et al., 2006).  
 
 
 
 
 
Fig. 2. Macroscopic appearance of ulcerative colitis/dysplasia, post formalin-fixed. Most of 
the endoscopic undetectable lesions were the flat and superficial elevated type 
macroscopically. (Red bar: UC-IV, Yellow bar: UC-III, Blue bar: UC-IIb) 
 
 
 
(a) Endoscopic finding (b) Stereomicroscopic finding 
Fig. 3. Endoscopic finding of the UC-III lesion. In non-dysplastic epithelium, circle and/or 
oval pits were scattered in the area (a). Stereomicroscopic finding of the UC-III lesion. The 
mucosal surface shows packed distribution of oval and/or club-like shape and/or branch-
like shaped pit (b). 
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T grade P value  Protruding Flat *P value 
Dysplasia(n=40)      
Detectable 19  3 16 0.058 
Undetectable 21  0 21  
Tis(n=15      
Detectable 10 0.205a 3 7 0.171 
Undetectable 5  0 5  
T1(n=5)      
Detectable 2 0.751a 2 0 <0.05 
Undetectable 3 0.292b 0 3  
Advanced (n=7)      
Detectable 7 <0.05 a 6 1 ND 
  0.082 b    
Undetectable 0 <0.05 c 0 0  
a Compared with dysplasia, b Compared with Tis, c Compared with T1. 
* Relationship between detection and macroscopic appearance. NF: not determined 
Table 2. Relationship between detection and macroscopic appearance of UC-associated 
lesions (adapted from Yamagishi et al., 2009)  
3.1 Histological diagnosis of ulcerative colitis/dysplasia 
UC associated dysplasia was a precursor of colitic cancer in UC, several studies have shown 
that UC-associated dysplasia correlates with the presence of colitic cancer. The existence of 
carcinoma at the time of colectomy in UC patients with high-grade dysplasia, as determined 
by a preoperative rectal biopsy. A presence of dysplasia could identify patients likely either 
to have or to develop colitic cancer. Thus, dysplasia is not only a precursor of colitic cancer, 
but may also be a marker for the existence of colitic cancer in other areas of the colorectum. 
Gastrointestinal surgical pathologist have been diagnosis inflammatory grade and epithelial 
injury on UC patient using by Matts grading system (Table 3) , The Inflammatory Bowel 
Disease Morphology Study Group in Western countries attempted to verify a standardized 
terminology and classification for the assessment of dysplasia in UC (Table 4). However, in 
Japan, the interpretation of‘dysplasia’ in UC varies from one pathologist to another. 
Therefore, the Research Committee on Inflammatory Bowel Disease of the Ministry of 
Health and Welfare of Japan proposed a new classification for UC associated 
dysplasia/neoplasia in 1993 (Table 5). 
 
 
Grade 1 Normal appearance. 
Grade 2 Some infiltration of the mucosa or lamina propria with either round cells or 
polymorphs. 
Grade 3 Much cellular of the mucosa or lamina propria and submucosa. 
Grade 4 Presence of crypt abscess, with much infiltration of all layers of the mucosa. 
Grade 5 Ulceration, erosion, or necrosis of the mucosa, with cellular infiltration of 
some or  all its layer. 
Table 3. The value of rectal biopsy in the diagnosis of ulcerative colitis (adapted from Matts , 
1961). 
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Negative 
Normal mucosa 
Inactive (quiescent) colitis 
Active colitis 
Indefinite 
Probably negative (probably inflammatory) 
Unknown 
Probably positive (probably dysplasia) 
Positive 
Low-grade dysplasia 
High-grade dysplasia 
Table 4. Biopsy classification of dysplasia in inflammatory bowel disease (adapted from 
Riddle et al., 1983). 
 
Category Description 
UC-I Inflammatory change 
UC-II Indefinite 
UC-IIa Probably inflammatory 
UC-IIb Probably neoplastic 
UC-III Neoplastic but not carcinoma 
UC-IV Carcinoma 
UC: ulcerative colitis.  
Table 5. Histological classification of the neoplasia epithelium arising in ulcerative colitis 
(adapted from Konishi et al., 1993). 
Matts grading system (Table 3) and UC associated dysplasia/neoplastic classification (Table 
4 & 5) are used for clinical and research purposes and applies to both colectomy and biopsy 
specimens. The histological characteristics of each stage of UC-associated dysplasia/ 
neoplasia with inflammatory lesion (Fig 4). However, it is difficult and sensitive to 
discriminate between UC-associated dysplasia and regenerative epithelium by the 
conventional Hematoxylin and Eosin staining section. Histological diagnosis of UC-
associated dysplasia/neoplasia is based on a combination of architectural and cytological 
alterations. The architectural alterations often result in glandular arrangements, e.g., club-
shaped villi, crawling glands or bifid formation at the base of the crypts. The cytological 
alterations comprise cellular and nuclear pleomorphism, nuclear hyperchromatism, loss of 
nuclear polarity, marked nuclear stratification, dystrophic goble cells and failure of 
maturation from the crypt base to the surface.  
3.2 Immunohistochemical finding of ulcerative colitis/dysplasia 
Pathologically, it is not rare those surgical pathologists are unable to distinguish between 
from UC-associated dysplasia/neoplasia and inflammatory regenerative epithelium using 
by hematoxylin and eosin staining. Furthermore, there are differences in the diagnostic 
criteria that different surgical pathologist use for dysplasia/neoplasia. In order to improve 
the accuracy of pathological diagnosis, it will be necessary to use ordinary method for 
immunohistochemical technique.   
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(a) Crawling crypts. (b) Dystrophic goblet cell 
 
(c) Distorted crypts with cellular atypia (d) Invasive crypt and crypt abscess 
Fig. 4. Histological appearance of UC-associated dysplasia/neoplasia on Hematoxylin and 
Eosin staining section. There are marked distorted and crawling crypts. This epithelium could 
be interpreted as UC-IIb with Matts grade 3 (a). There are a lot of goblet cells, so-called 
dystrophic goblet cell. This epithelium could be interpreted as UC-IIb with Matts grade 3 (b). 
There are marked distorted crypts with cellular atypia. This epithelium could be interpreted as 
UC-III with Matts grade 3 (c). Neoplastic crypts with submucosal invasion. This epithelium 
could be interpreted as UC-IV with Matts grade 4 including crypt abscess. (d).  
3.2.1 P53 protein nuclear accumulation  
Several reports have shown that the rate of the tumor suppressor p53 gene alteration is high 
in UC-associated dysplasia/neoplasia (Lashner et al., 1999). Immunohistochemical analysis 
of P53 protein is a useful and easy method for detecting p53 gene alterations. In our study, 
59.5% of neoplastic lesions (UC-III and IV) and 40.0% of lesions that were probably 
neoplastic (UC-IIb) displayed nuclear accumulation of P53 protein (Fujii et al., 2003a). Thus, 
immunohistochemical analysis of P53 could be a useful marker of UC associated 
dysplasia/neoplasia in cases where discriminating between neoplasia and regenerative 
epithelium is difficult (Fig 5) (Table 6). 
3.2.2 Increased expression of DNA Methyltransferase -1   
Neoplastic progression in UC occurs in a histologically stepwise manner, from chronic 
epithelial inflammation to dysplasia/neoplasia, and the process of neoplastic progression 
involves accumulation of genetic and epigenetic alterations. Some of these alterations are  
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(a) Hematoxylin and Eosin (b) P53 protein 
Fig. 5.  Mucin droplets are well preserved but have lost their normal polarity, being present 
apically or basally or lateral to the nucleus (a). This epithelium could be interpreted as UC-
IIb. Immunohistochemistry analysis revealed normal accumulated P53 protein in the 
nucleus (b).  
 
Histological diagnosis n Positive staining(%) 
Inflammatory change (UC-I) 5 0(0) 
Indefinite, probably inflammatory (UC-IIa) 38 0(0) 
Indefinite, probably neoplastic (UC-IIb) 35 14(40.0) 
Neoplastic but not carcinoma (UC-III) 24 14(58.3) 
Carcinoma (UC-IV) 18 11(61.1) 
Table 6. Relation between nuclear accumulations of P53 protein and histological diagnosis 
(adapted from Fujii et al., 2003a) 
known to occur in both the neoplastic and nonneoplastic epithelium of UC patients with  
neoplasia, and are considered to be widespread and to occur early in the process of 
neoplastic progression. In several types of neoplasia, aberrant methylation of promoter-
region CpG islands, as an epigenetic modification of DNA, is associated with transcriptional 
inactivation of tumor suppressor genes and plays a crucial role in the development and 
progression of neoplasia (Hsieh et al., 1998). DNA methylation results from a methyl 
transfer reaction performed by the three active DNA methyltransferases (DNMTs): DNMT1, 
DNMT3a and DNMT3b (Okano et al., 1999).  Of these, DNMT1 is the most abundant DNMT 
targeted to replication foci and has a preference for hemimethylated DNA substrates.  
Recent investigations have shown that DNMT1 is overexpressed in tumorigenic cells and 
several types of human tumors, and that increased expression of DNMT1 is dependent on 
cell proliferation. We reported that the immunoreactive DNMT1 expression gradually 
increased from rectal epithelium of UC patients without neoplasia to nonneoplastic rectal 
epithelium of UC patients with neoplasia (p <0.001), and to colorectal neoplasia (p <0.001) 
(Fujii et al., 2010). Among 31 neoplasias, there was no difference in the immunoreactive 
DNMT1 expressions between dysplasia and invasive cancer. Expression of DNMT1 in  
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non-neoplastic epithelium may precede or be a relatively early event in UC-associated 
carcinogenesis (Fig. 6). 
 
 
 
 
(a) Non-neoplastic epithelium without colitic cancer 
 
 
 
 
(b) Non-neoplastic epithelium with colitic cancer 
 
 
 
 
(c) Colitic cancer. 
Fig. 6. Immunohistochemical staining for DNMT1 protein in non-neoplastic rectal 
epithelium from UC patients without neoplasia (a), non-neoplastic rectal epithelium from 
UC patients with neoplasia (b) and colorectal neoplasia (c). 
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3.3 Molecular alterations of ulcerative colitis/dysplasia 
Numerous reports have revealed molecular alterations (e.g., K-Ras gene mutation, p16 gene 
hypermethylation, p14 gene hypermethylation, p53 gene mutation, DNA aneuploidy, 
chromosomal instability, microsatellite instability, age-related methylation, telomere length 
shortening) of nonneoplastic epithelium in UC patients with neoplasia (Brentnail et al., 1994, 
Holzmann et al., 2001, Fujii et al., 2005). Several of these reports have indicated higher 
frequencies of molecular alterations to nonneoplastic epithelium in UC patients with 
dysplasia/neoplasia than in nonneoplastic epithelium in UC patients without neoplasia, 
suggesting that these molecular alterations may be applicable as new markers for 
identifying individuals with UC at increased risk of neoplasia. 
3.3.1 P53 gene abnormalities    
In the p53 gene, point mutations have been reported in 40–50% and LOH in 80% of sporadic 
colorectal cancers (Baker et al., 1990). However, these genetic alterations of the p53 gene 
have only been found in approximately 10% of sporadic adenomas. These data suggest that 
genetic alterations in the p53 gene are involved in the progression from adenoma to cancer. 
Alterations in p53 gene were reported in both UC-associated dysplasia and colitic cancer at 
an incidence of about 50–80%.The point mutations in p53 gene were detected in 48% of case 
of UC-associated dysplasia, and that both point mutation and allelic loss were found in 
more than 80% of cases of colitic cancer (Brentnail et al., 1994. When the p53 gene has a 
nonsense mutation or frameshift, the P53 protein does not accumulate in the nucleus despite 
the alteration. In fact, 92.9% of the neoplastic lesions that displayed negative 
immunohistochemical staining for P53 protein demonstrated a p53 gene mutation within 
exons 5–8 under PCR singlestranded conformation polymorphism (Fujii et al., 2003a). This 
suggests that screening for p53 gene mutation using PCR single-stranded conformation 
polymorphism is more accurate than immunohistochemistry for discriminating between 
UC-associated neoplasia and regenerative epithelium. 
3.3.2 Age-related methylation and methylation analysis of ER Gene 
In several neoplasias, aberrant methylation of promoter region Chg. islands, as an epigenetic 
modification of DNA, is associated with transcriptional inactivation of tumor suppressor 
genes and plays a crucial role in the development and progression of neoplasia (Hsieh et al., 
1998).  In normal colorectal epithelium, some genes are methylated with aging, and this 
alteration is known as age-related methylation. A methylation of the estrogenic receptor 
(ER) Chg. Island increased with age in no neoplastic colorectal epithelium and that the same 
methylation occurred in most sporadic colorectal neoplasias (Isa et al. 1994). They concluded 
that methylation of the ER gene in aging colorectal epithelium could represent one of the 
earliest events predisposing to sporadic colorectal carcinogenesis. Therefore, in our recent 
study (Fujii et al., 2005 and Tominaga et al., 2005), we analysed ER gene methylation in 
multiple samples taken from 6 regions throughout the colorectum: the rectum, sigmoid 
colon, descending colon, transverse colon, ascending colon and cecum (Fig. 7). Non-
neoplastic colorectal epithelia from patients with longstanding and extensive UC, including 
8 UC patients with neoplasia and 10 patients without, were evaluated. The combined 
bisulfite restriction analysis method (COBRA) was used to determine the methylation status 
of the ER gene. The mean methylation level of the ER gene was 25.4% in the nonneoplastic 
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epithelia from UC patients with neoplasia, whereas it was only4.0 % in those without 
neoplasia (P < 0.001). The methylation level of the ER gene in UC patients with neoplasia 
was significantly higher than in UC patients without neoplasia throughout the colorectum 
except for the cecum. In UC patients with neoplasia, the mean ER methylation level in the 
distal colon was significantly higher than in the proximal colon (P < 0.001) Analysis of ER 
gene methylation may have potential as a useful marker for identifying individuals at 
increased risk of neoplasia among those with longstanding and extensive UC. 
 
 
 
(a) Non-neoplastic colon epithelium with colitic cancer 
 
 
(b) Non-neoplastic colon epithelium without colitic cancer 
Fig. 7. COBRA for the ER gene in each region of the non-neoplastic epithelium of the 
colorectum from patient with UC-associated neoplasia (a) and without UC-associated 
neoplasia (b). UM, the unmethylated breast cancer cell line MCF-7; M, the methylated colon 
cancer cell line DLD-1; R, rectum; S, sigmoidcolon; D, descending colon; T, transverse colon; 
A, ascending colon; C, cecum. A, representative samples 
4. Conclusion  
In this issue, we have discussed the efficacy of surveillance colonoscopy for UC associated 
dysplasia/neoplasia, several problems related to the diagnosis of UC–associated 
dysplasia/neoplasia and molecular markers that can be used to identify individuals with 
UC at increased risk of dysplasia/neoplasia. Current surveillance colonoscopy remains 
unsatisfactory, due to difficulties with endoscopic and histological diagnosis of UC-
associated dysplasia/neoplasia. These difficulties may be overcome by introducing 
adjunctive techniques for diagnosing UC-associated dysplasia/neoplasia, analysis of p53 
gene alteration and/or new endoscopic system. However, it seems impartial for all UC 
patients with conventional risk factors, long-standing disease and extensive colitis to 
undergo close surveillance colonoscopy using such techniques. In order to realize the full 
potential of close surveillance colonoscopy, higher-risk groups selecting from patients with 
long – standing and extensive UC. Analyses of age-related methylation and expression of 
DNMT1 in nonneoplastic epithelium may allow identification of such higher-risk patients.  
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